Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease

Brain and Development

Volumn 22, Issue 2, 2000, Pages 127-131

  Al Essa, Mohammed A ^a   Bakheet, Siema M ^a   Patay, Zoltan J ^a   Powe, John E ^a   Ozand, Pinar T ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

4 hydroxybutyric aciduria; Clinical and biochemical findings; MRI and FDG PET brain scans

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 HYDROXYBUTYRIC ACID; DEXTROMETHORPHAN; VIGABATRIN;

4 AMINOBUTYRIC ACID METABOLISM; ACIDURIA; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BRAIN DYSFUNCTION; BRAIN METABOLISM; CASE REPORT; CEREBELLUM ATROPHY; CHILD; DEAFFERENTATION; DEVELOPMENTAL DISORDER; ELECTROENCEPHALOGRAM; HUMAN; MALE; METABOLIC DISORDER; MUSCLE HYPOTONIA; MYOCLONUS EPILEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; URINALYSIS;

BRAIN; CHILD, PRESCHOOL; DEXTROMETHORPHAN; FLUORODEOXYGLUCOSE F18; HUMANS; HYDROXYBUTYRATES; MAGNETIC RESONANCE IMAGING; MALE; METABOLISM, INBORN ERRORS; SAUDI ARABIA; TOMOGRAPHY, EMISSION-COMPUTED; VIGABATRIN;

EID: 0034646240     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(99)00121-7     Document Type: Article

References (18)

1. Rahbeeni Z., Ozand P.T., Rashed M., Gascon G.G., Al Nasser M., Al Odaib A., et al. 4-Hydroxybutyric aciduria. Brain Dev. 16:1994;64-71.
2. Gibson K.M., Jansen I., Sweetman L., Nyhan W.L., Rating D., Jakobs C. 4-Hydroxybutyric aciduria: a new inborn error of metabolism. III. Enzymology and inheritance. J Inher Metab Dis. 7:1984;95-96.
3. Snead O.C. Gamma hydroxybutyrate. Life Sci. 20:1977;1935-1944.
4. Onkenhout W., Maaswinkel-Mooij P.D., Poorthuis B.J.H.M. 4-Hydroxybutyric aciduria: further clinical heterogeneity in a new case. Eur J Pediatr. 149:1989;194-196.
5. Gibson K.M., Aramaki S., Sweetman L., Nyhan W.L., DeVivo D.C., Hodson A.K., et al. Stable isotope dilution analysis of 4-hydroxybutyric acid: an accurate method of quantification in physiological fluids and the prenatal diagnosis of 4-hydroxybutyric aciduria. Biomed Envirom Mass Spectrom. 19:1990;89-93.
6. Brown G.K., Cromby C.H., Manning N.J., Pollitt R.J. Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alfa-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation. J Inher Metab Dis. 10:1987;367-375.
7. Tortella F.C., Pellicano M., Bowery N.G. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci. 10:1989;501-507.
8. Uziel G., Bardelli P., Pantaleoni C., Rimoldi M., Savoiardo M. 4-Hydroxybutyric aciduria: clinical findings and vigabatrin therapy. J Inher Metab Dis. 16:1993;520-522.
9. Gibson K.M., De Vivo D.C., Jakobs C. Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency. Lancet. 2:1989;1105-1106.
10. Jakobs C., Michael T., Jaeger E., Jaeger E., Jaeken J., Gibson K.M. Further evaluation of vigabatrin therapy in 4-hydroxybutyric aciduria. Eur J Paediatr. 151:1992;466.
11. Chugani H.T. Functional brain imaging in pediatrics. Pediatr Clin North Am. 39:1992;777-799.
12. 18FDG) PET scan of the brain in glutaric aciduria type 1: clinical and MRI correlations. Brain Dev. 20:1998;295-301.
13. Bakheet S., Al-Essa M., Patay Z., Al-Watban J., Dhaunsi G., Powe J., et al. Cerebral fluorine-18 fluorodeoxyglucose positron emission tomographic findings in X-linked adrenoleukodystrophy. Clin Nucl Med. 24:1999;364-365.
14. 18FDG) PET scan of the brain scan in type IV 3-methylglutaconic aciduria: clinical and MRI correlations. Brain Dev. 21:1999;24-29.
15. 18Fluoro-2-deoxyglucose positron emission tomographic findings in ethylmalonic aciduria, a progressive neurometabolic disease. Eur J Paediatr Neurol. 3:1999;125-127.
16. Al-Essa M., Al Amir A., Rashed M., Al Jishi E., Abutaleb A., Mobaireek K., et al. Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography of the brain, MR spectroscopy, and therapeutic attempts in methylenetetrahydrofolate reductase deficiency. Brain Dev. 21:1999;345-349.
17. 18FDG) PET scan of the brain in propionic acidemia: clinical and MRI correlations. Brain Dev. 21:1999;312-317.
18. Al-Essa M., Al-Hussein K., Ozand P.T. 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET scan of the brain in maple syrup urine disease. Clin Nucl Med. 24:1999;612-613.